• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MEM
Click for more information
16.7% 0.5¢

MEMPHASYS LIMITED. - Announcements

Market Cap $13.00M  ! watchlist Created with Sketch. Add to my watchlist

Memphasys Limited is an Australia-based reproductive biotechnology company. The Company... Memphasys Limited is an Australia-based reproductive biotechnology company. The Company is engaged in developing medical devices, diagnostics, and media with application to assisted reproductive technology (ART) in humans and animals. The Company's product pipeline includes Felix, RoXsta, and AI-Port. Its advanced product, the Felix System, is a patented automated device for quickly and gently separating sperm from a semen sample for use in ART procedures. The Felix device consists of two main components: a console, which supplies electrical power, and a sterile disposable cartridge for sperm isolation and selection. RoXsta is an in-vitro diagnostic device that assesses semen and other bodily fluids for oxidative stress load. RoXsta also has an application as part of a suite of products that can support the animal industry. AI-Port has been developed for the purpose of maintaining the viability of livestock semen for up to seven days at a temperature range of 22 - 25 degrees Celsius.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
MEMNuSep Restructures Board and Company to Focus on PrIME technPRICE SENSITIVE16/08/12
MEMNSP receives S$6M investment in Singapore Plasma BusinesssPRICE SENSITIVE14/08/12
MEMChange in substantial holding24/07/12
MEMAppendix 3B20/07/12
MEMChange in substantial holding25/06/12
MEMChange of Director's Interest Notice25/06/12
MEMResults of Meeting22/06/12
MEMNuSep General Meeting presentation 201222/06/12
MEMNuSep Settles NxGen Legal CasePRICE SENSITIVE14/06/12
MEMNuSep Investor Presentation06/06/12
MEMNuSep Expands Gels Distribution with BioExpress in the USPRICE SENSITIVE05/06/12
MEMNuSep Lodges Two Patent ApplicationsPRICE SENSITIVE29/05/12
MEMChange of Company Secretary25/05/12
MEMNotice of General Meeting/Proxy Form22/05/12
MEMNuSep raises $200,00018/05/12
MEMLetter from the Chairman16/05/12
MEMProposal to change auditor of the Company14/05/12
MEMHOA to establish Singapore Plasma Fractionation FacilityPRICE SENSITIVE26/04/12
MEMAppendix 3B18/04/12
MEMAppendix 3B04/04/12
MEMUpdate on Payment of $1.8M on Exercise of Share OptionsPRICE SENSITIVE02/04/12
MEMNuSep Working Capital AdvancePRICE SENSITIVE30/03/12
MEMNotice to holders of 15 cent options (NSPOA)23/03/12
MEMFinal Director's Interest Notice20/03/12
MEMNuSep Board Changes19/03/12
MEMInitial Director's Interest Notice16/03/12
MEMAndrew Goodall Joins NuSep Board14/03/12
MEMResponse to ASX Letter re Disclaimer of Audit Opinion12/03/12
MEMNuSep signs Distribution Agreement with In Vitro TechnologiePRICE SENSITIVE06/03/12
MEMCorrection to Appendix 4DPRICE SENSITIVE01/03/12
MEMNuSep announces Half Year ProfitPRICE SENSITIVE29/02/12
MEMDirector Resignation and Appendix 3Z20/02/12
MEMProfessor John Aitken receives award for SpermSep technology16/12/11
MEMLetter to Shareholders12/12/11
MEMNuSep Transfer of shares held in suspense account12/12/11
MEMBecoming a substantial holder30/11/11
MEMResults of Annual General Meeting29/11/11
MEMNuSep AGM presentation 201129/11/11
MEMExercise of 12m 15cent Share OptionsPRICE SENSITIVE25/11/11
MEMConversion of $150,000 of ConvNotes/Exercise of ShareOptions23/11/11
MEMNuSep Settles Legal case with Expedeon16/11/11
MEMAppointment of a New Company Secretary07/11/11
MEMAnnual Report31/10/11
MEMNotice of Annual General Meeting/Proxy Form27/10/11
MEMNBN News IVF Story on Professor Aitken24/10/11
MEMResponse to ASX Query21/10/11
MEMAppendix 3B20/10/11
MEMInitial Director's Interest Notice20/10/11
MEMChange of Director's Interest Notice20/10/11
MEMConversion of $225,000 of Convertible NotesPRICE SENSITIVE17/10/11
MEMNuSep Letter from the ChairmanPRICE SENSITIVE10/10/11
MEMIssue of Bonus Listed 15c Share Options06/10/11
MEMChange of Director's Interest Notices05/10/11
MEMAnnual Financial Report30/09/11
MEMSPO - Appendix 3B30/09/11
MEMNotice to 35 cents option holders21/09/11
MEMChange in substantial holding20/09/11
MEMAppendix 3B14/09/11
MEMResults of Meeting09/09/11
MEMAppendix 3Y Change of Director's Interest Notice06/09/11
MEMAppendix 3Y Change of Director's Interest Notice02/09/11
MEMAppendix 3Y Change of Director's Interest Notice02/09/11
MEMNuSep Raises $1.9m via SPO31/08/11
MEMPreliminary Final ReportPRICE SENSITIVE31/08/11
MEMAppendix 3Y Change of Director's Interest Notices30/08/11
MEMAppendix 3Y Change of Director's Interest Notice25/08/11
MEMAppendix 3Y Change of Director's Interest Notice22/08/11
MEMShareholder Newsletter17/08/11
MEMAppendix 3Y Change of Director's Interest Notice16/08/11
MEMNuSep Extends the SPO Closing Date to 26th August 201115/08/11
MEMNuSep 15c Bonus Share OptionsPRICE SENSITIVE12/08/11
MEMAppendix 3Y Change of Director's Interest Notice12/08/11
MEMNotice of General Meeting/Proxy Form11/08/11
MEMAppendix 3B11/08/11
MEMNuSep ASIC Form 48410/08/11
MEMAppendix 3Y Change of Director's Interest Notice08/08/11
MEMAppendix 3Y Change of Director's Interest Notice03/08/11
MEMNSP Letter from the Chairman02/08/11
MEMNuSep Extends the SPO Closing Date to 15th August 201129/07/11
MEMAppendix 3Y Change of Director's Interest Notice29/07/11
MEMNuSep Investor Presentation28/07/11
MEMNuSep Signs Letter of Intent with United LaboratoriesPRICE SENSITIVE27/07/11
MEMNuSep 15c Bonus Share Option Issue27/07/11
MEMSingapore Government Provides Financial and Economic SuppPRICE SENSITIVE25/07/11
MEMNuSep SPO Update and Investor Meetings07/07/11
MEMNuSep SPO ProspectusPRICE SENSITIVE06/07/11
MEMNuSep Investor Presentation06/07/11
MEMNuSep signs 3 Year Gels Distribution AgreementPRICE SENSITIVE28/06/11
MEM$1.5m Underwriting of the SPO and Investor MeetingsPRICE SENSITIVE22/06/11
MEMNuSep 1 for 2 Bonus Options for All Shareholders22/06/11
MEMPart Settlement of US Intellectual Property Legal CasePRICE SENSITIVE20/06/11
MEMNuSep Announces a Bonus Issue and SPP UpdatePRICE SENSITIVE20/06/11
MEMNuSep Announces a SPPPRICE SENSITIVE14/06/11
MEMNuSep Launches ProteoIQ V 2.2 at ASMS10/06/11
MEMNuSep Market UpdatePRICE SENSITIVE27/05/11
MEMProf John Aitken inducted into the Aust Academy of Science10/05/11
MEMNuSep Launches New GelsPRICE SENSITIVE08/04/11
MEMDeveloper of NuSep SpermSep Elected to Australian Academy04/04/11
MEMChange in substantial holding18/03/11
MEMAppendix 3B Issue of Bonus Share Options18/03/11
MEMNuSep Restructures Board and Company to Focus on PrIME techn
16/08/12PRICE SENSITIVE
MEMNSP receives S$6M investment in Singapore Plasma Businesss
14/08/12PRICE SENSITIVE
MEMChange in substantial holding
24/07/12
MEMAppendix 3B
20/07/12
MEMChange in substantial holding
25/06/12
MEMChange of Director's Interest Notice
25/06/12
MEMResults of Meeting
22/06/12
MEMNuSep General Meeting presentation 2012
22/06/12
MEMNuSep Settles NxGen Legal Case
14/06/12PRICE SENSITIVE
MEMNuSep Investor Presentation
06/06/12
MEMNuSep Expands Gels Distribution with BioExpress in the US
05/06/12PRICE SENSITIVE
MEMNuSep Lodges Two Patent Applications
29/05/12PRICE SENSITIVE
MEMChange of Company Secretary
25/05/12
MEMNotice of General Meeting/Proxy Form
22/05/12
MEMNuSep raises $200,000
18/05/12
MEMLetter from the Chairman
16/05/12
MEMProposal to change auditor of the Company
14/05/12
MEMHOA to establish Singapore Plasma Fractionation Facility
26/04/12PRICE SENSITIVE
MEMAppendix 3B
18/04/12
MEMAppendix 3B
04/04/12
MEMUpdate on Payment of $1.8M on Exercise of Share Options
02/04/12PRICE SENSITIVE
MEMNuSep Working Capital Advance
30/03/12PRICE SENSITIVE
MEMNotice to holders of 15 cent options (NSPOA)
23/03/12
MEMFinal Director's Interest Notice
20/03/12
MEMNuSep Board Changes
19/03/12
MEMInitial Director's Interest Notice
16/03/12
MEMAndrew Goodall Joins NuSep Board
14/03/12
MEMResponse to ASX Letter re Disclaimer of Audit Opinion
12/03/12
MEMNuSep signs Distribution Agreement with In Vitro Technologie
06/03/12PRICE SENSITIVE
MEMCorrection to Appendix 4D
01/03/12PRICE SENSITIVE
MEMNuSep announces Half Year Profit
29/02/12PRICE SENSITIVE
MEMDirector Resignation and Appendix 3Z
20/02/12
MEMProfessor John Aitken receives award for SpermSep technology
16/12/11
MEMLetter to Shareholders
12/12/11
MEMNuSep Transfer of shares held in suspense account
12/12/11
MEMBecoming a substantial holder
30/11/11
MEMResults of Annual General Meeting
29/11/11
MEMNuSep AGM presentation 2011
29/11/11
MEMExercise of 12m 15cent Share Options
25/11/11PRICE SENSITIVE
MEMConversion of $150,000 of ConvNotes/Exercise of ShareOptions
23/11/11
MEMNuSep Settles Legal case with Expedeon
16/11/11
MEMAppointment of a New Company Secretary
07/11/11
MEMAnnual Report
31/10/11
MEMNotice of Annual General Meeting/Proxy Form
27/10/11
MEMNBN News IVF Story on Professor Aitken
24/10/11
MEMResponse to ASX Query
21/10/11
MEMAppendix 3B
20/10/11
MEMInitial Director's Interest Notice
20/10/11
MEMChange of Director's Interest Notice
20/10/11
MEMConversion of $225,000 of Convertible Notes
17/10/11PRICE SENSITIVE
MEMNuSep Letter from the Chairman
10/10/11PRICE SENSITIVE
MEMIssue of Bonus Listed 15c Share Options
06/10/11
MEMChange of Director's Interest Notices
05/10/11
MEMAnnual Financial Report
30/09/11
MEMSPO - Appendix 3B
30/09/11
MEMNotice to 35 cents option holders
21/09/11
MEMChange in substantial holding
20/09/11
MEMAppendix 3B
14/09/11
MEMResults of Meeting
09/09/11
MEMAppendix 3Y Change of Director's Interest Notice
06/09/11
MEMAppendix 3Y Change of Director's Interest Notice
02/09/11
MEMAppendix 3Y Change of Director's Interest Notice
02/09/11
MEMNuSep Raises $1.9m via SPO
31/08/11
MEMPreliminary Final Report
31/08/11PRICE SENSITIVE
MEMAppendix 3Y Change of Director's Interest Notices
30/08/11
MEMAppendix 3Y Change of Director's Interest Notice
25/08/11
MEMAppendix 3Y Change of Director's Interest Notice
22/08/11
MEMShareholder Newsletter
17/08/11
MEMAppendix 3Y Change of Director's Interest Notice
16/08/11
MEMNuSep Extends the SPO Closing Date to 26th August 2011
15/08/11
MEMNuSep 15c Bonus Share Options
12/08/11PRICE SENSITIVE
MEMAppendix 3Y Change of Director's Interest Notice
12/08/11
MEMNotice of General Meeting/Proxy Form
11/08/11
MEMAppendix 3B
11/08/11
MEMNuSep ASIC Form 484
10/08/11
MEMAppendix 3Y Change of Director's Interest Notice
08/08/11
MEMAppendix 3Y Change of Director's Interest Notice
03/08/11
MEMNSP Letter from the Chairman
02/08/11
MEMNuSep Extends the SPO Closing Date to 15th August 2011
29/07/11
MEMAppendix 3Y Change of Director's Interest Notice
29/07/11
MEMNuSep Investor Presentation
28/07/11
MEMNuSep Signs Letter of Intent with United Laboratories
27/07/11PRICE SENSITIVE
MEMNuSep 15c Bonus Share Option Issue
27/07/11
MEMSingapore Government Provides Financial and Economic Supp
25/07/11PRICE SENSITIVE
MEMNuSep SPO Update and Investor Meetings
07/07/11
MEMNuSep SPO Prospectus
06/07/11PRICE SENSITIVE
MEMNuSep Investor Presentation
06/07/11
MEMNuSep signs 3 Year Gels Distribution Agreement
28/06/11PRICE SENSITIVE
MEM$1.5m Underwriting of the SPO and Investor Meetings
22/06/11PRICE SENSITIVE
MEMNuSep 1 for 2 Bonus Options for All Shareholders
22/06/11
MEMPart Settlement of US Intellectual Property Legal Case
20/06/11PRICE SENSITIVE
MEMNuSep Announces a Bonus Issue and SPP Update
20/06/11PRICE SENSITIVE
MEMNuSep Announces a SPP
14/06/11PRICE SENSITIVE
MEMNuSep Launches ProteoIQ V 2.2 at ASMS
10/06/11
MEMNuSep Market Update
27/05/11PRICE SENSITIVE
MEMProf John Aitken inducted into the Aust Academy of Science
10/05/11
MEMNuSep Launches New Gels
08/04/11PRICE SENSITIVE
MEMDeveloper of NuSep SpermSep Elected to Australian Academy
04/04/11
MEMChange in substantial holding
18/03/11
MEMAppendix 3B Issue of Bonus Share Options
18/03/11
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
0.5¢ 		Change
-0.001(16.7%) 		Mkt cap ! $13.00M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $19.10K 3.821M

Buyers (Bids)

No. Vol. Price($)
11 4204169 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 5374720 3
View Market Depth
Last trade - 15.56pm 07/11/2024 (20 minute delay) ?
Last
0.6¢ 		  Change
-0.001 ( 10.0 %)
Open High Low Volume
0.5¢ 0.6¢ 0.5¢ 1763959
Last updated 15.05pm 07/11/2024 ?
MEM (ASX) Chart

Top Stories

Pantera begins drilling of maiden test well at Smackover

Pantera Minerals Ltd has commenced drilling of its first test well at the Smackover Lithium Brine Project in Arkansas
Palladium's the newest geopolitical hot commodity. But ASX exposure is limited On October 24, the USA reportedly approached its G7 counterparts and proposed a ban on Russian titanium, and, palladium.
C29 Metals wins Kazakhstani uranium drill run green tick, Kazatomprom talks mature C29 Metals appears to be making an eye catching relationship work in its favour – one with Kazakhstani uranium producer Kazatomprom.
The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint Let’s get straight to the point: of all the smallcaps in the Telecommunications index, The Market Ltd could be one of the most overlooked.
Aerospace smallcap Quickstep Holdings jumps nearly 100% after 40cps takeover offer Quickstep Holdings (ASX:QHL) has received a takeover offer for 40cps, sending shares 100% higher as the stock doubled its price on Thursday.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.